SEC Filing Summary: Spherix Incorporated (Form 8-K)
Business Context and Reporting Period
This Form 8-K was filed by Spherix Incorporated on June 18, 2012. The filing serves as a current report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. The registrant is incorporated in Delaware and maintains its principal executive offices in Bethesda, Maryland.
Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This document is a disclosure notice rather than a financial statement.
Material Changes
No material financial changes or operational updates are detailed in the body of this filing. The report focuses solely on the disclosure of a corporate presentation.
Guidance, Outlook, and Management Commentary
Under Item 7.01 (Regulation FD Disclosure), the company announced that Dr. Claire Kruger (CEO) and Dr. Robert Lodder (President) delivered a presentation to prospective investors at the Bio International Convention & Exhibition Center in Boston, MA. The presentation, titled "Spherix Incorporated Overview Presentation," is attached as Exhibit 99.1 and is available on the company's website. No specific guidance or risk factors are enumerated in this filing text.
Key Facts for Investor Verification
- Verify the content of the investor presentation attached as Exhibit 99.1 for specific business updates.
- Confirm the company's current financial status via its most recent 10-K or 10-Q filings, as this 8-K contains no financial data.
- Note the filing date of June 18, 2012, and the involvement of the CEO and President in the disclosed event.